Semaglutide vs. Tirzepatide: Which GLP-1 Is Right for You?

If you've been researching medical weight loss in El Paso, you've probably come across two names again and again: semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound). Both belong to a class of medications called GLP-1 receptor agonists, and both have transformed the way we approach weight management.

But they're not the same medication. They work through different mechanisms, produce different levels of weight loss, have slightly different side effect profiles, and come at different price points. At Solas Health & Wellness, we prescribe both — and the right choice depends on your body, your goals, and your health history.

This guide breaks down everything you need to know so you can have a more informed conversation with your provider.

How They Work: One Receptor vs. Two

Understanding the science behind these medications helps explain why they produce different results.

Semaglutide (Ozempic / Wegovy)

Semaglutide is a GLP-1 receptor agonist. It mimics a natural hormone called GLP-1 (glucagon-like peptide-1) that your body releases after eating. GLP-1 tells your brain you're full, slows stomach emptying so food stays with you longer, and helps regulate blood sugar by improving insulin response.

When you take semaglutide, these signals are amplified. You feel satisfied with less food, cravings decrease, and your body processes glucose more efficiently. It was originally developed for type 2 diabetes (as Ozempic) and later approved for weight management (as Wegovy) after clinical trials showed significant weight loss.

Tirzepatide (Mounjaro / Zepbound)

Tirzepatide is a dual GIP/GLP-1 receptor agonist. It activates the same GLP-1 receptor as semaglutide, but it also activates a second receptor: GIP (glucose-dependent insulinotropic polypeptide). This dual action is what makes tirzepatide different.

The GIP receptor plays a role in fat metabolism, insulin secretion, and how your body stores and uses energy. By targeting both pathways simultaneously, tirzepatide produces a more pronounced effect on appetite, blood sugar, and body composition. Some researchers believe the GIP component may also help reduce the severity of GI side effects, since the two pathways can moderate each other.

Weight Loss Results: What the Clinical Data Shows

The most meaningful comparison came in 2025 with the publication of the SURMOUNT-5 trial in the New England Journal of Medicine — the first large, head-to-head study directly comparing these two medications in people with obesity (without diabetes).

SURMOUNT-5 Trial Highlights

This Phase 3b trial randomized 751 participants to receive either the maximum tolerated dose of tirzepatide (10 mg or 15 mg) or semaglutide (1.7 mg or 2.4 mg) weekly for 72 weeks. The results were clear:

What This Means in Real Numbers

For a 220 lb patient, 13.7% weight loss with semaglutide means losing about 30 lbs. With tirzepatide at 20.2%, that same patient would lose about 44 lbs. That's a meaningful difference — but both outcomes are clinically significant and life-changing for most patients.

Real-world data from 2025-2026 largely confirms these findings. In a 12-month observational study of patients in remote weight management programs, tirzepatide patients lost an average of 22.1% of their body weight, while semaglutide patients lost 17.1%. Real-world results often exceed clinical trial outcomes because patients are more motivated and have access to ongoing provider support.

Side Effects: What to Expect

Both semaglutide and tirzepatide share a similar side effect profile, and most side effects are GI-related. They tend to be most noticeable during dose increases and typically improve as your body adjusts.

A key finding from comparative safety research is that semaglutide tends to have higher rates of vomiting, constipation, and GERD, while tirzepatide's dual-receptor mechanism may help moderate some of these effects. For patients who've struggled with nausea on semaglutide, switching to tirzepatide is a reasonable option to discuss with your provider.

Managing Side Effects

At Solas Health, we use a gradual dose titration protocol for both medications. Starting at the lowest dose and increasing slowly over several weeks gives your body time to adapt and significantly reduces the severity of GI side effects. We also provide dietary guidance — eating smaller meals, staying hydrated, and avoiding high-fat foods during dose increases can make a real difference in how you feel.

Dosing Schedules: How Each Medication Works

Both medications are administered as once-weekly subcutaneous injections using pre-filled pens. The injection itself takes seconds and most patients find it easy to self-administer at home.

The titration process is similar for both: you start low, increase gradually, and find the dose that produces meaningful weight loss without intolerable side effects. Your provider at Solas Health monitors your progress at each step and adjusts as needed.

Cost Comparison in El Paso

Cost is one of the biggest factors for patients deciding between these medications — especially without insurance coverage. Here's what the current pricing landscape looks like:

Who Should Choose Semaglutide?

Semaglutide may be the better starting point if:

• You're new to GLP-1 medications — semaglutide has a longer track record (FDA approved for weight loss since 2021) and more published long-term safety data.
• Cost is a primary concern — compounded semaglutide programs tend to be slightly more affordable, and the oral form (Rybelsus) eliminates the need for injections entirely.
• You have type 2 diabetes — semaglutide has extensive evidence for glycemic control and cardiovascular risk reduction.
• You prefer the most-studied option — semaglutide has been in clinical use longer, with more published data on sustained outcomes.
• Your weight loss goal is moderate — if you need to lose 10-15% of your body weight, semaglutide is often more than sufficient.

Who Should Choose Tirzepatide?

Tirzepatide may be the better choice if:

• You want maximum weight loss — the SURMOUNT-5 data consistently shows greater average weight loss with tirzepatide at equivalent treatment durations.
• You've plateaued on semaglutide — the additional GIP receptor activity may break through a weight loss plateau.
• You had significant GI side effects on semaglutide — tirzepatide's dual mechanism may produce less vomiting and constipation for some patients.
• You have significant insulin resistance — the dual GIP/GLP-1 action provides enhanced metabolic benefits beyond what GLP-1 alone offers.
• Your weight loss goal is aggressive — if you need to lose 20%+ of your body weight, tirzepatide has a higher probability of reaching that target.

Can You Switch Between Them?

Yes. Switching from semaglutide to tirzepatide (or vice versa) is common and safe when done under medical supervision. Common reasons patients switch include hitting a weight loss plateau, experiencing persistent side effects, or wanting to try the other option based on new clinical data.

When switching, your provider will typically start the new medication at a lower dose and titrate up, similar to starting from scratch. At Solas Health, we monitor your progress closely during any transition to ensure your body adjusts smoothly.

What About Oral GLP-1 Medications?

If you're not comfortable with weekly injections, there are options to be aware of. Oral semaglutide (Rybelsus) is available as a daily pill for type 2 diabetes, and a higher-dose oral formulation for weight loss has been in clinical development. Additionally, new oral GLP-1 medications like orforglipron are progressing through clinical trials and may offer pill-based alternatives in the near future.

At Solas Health, we stay current with the latest developments and can discuss all available options during your consultation.

The El Paso Factor: Why Local Care Matters

You can order GLP-1 medications from telehealth platforms that ship to El Paso, and many patients do. But there are real advantages to working with a local provider:

• In-person evaluations — your provider can assess things that a video call can't, including body composition, injection technique, and physical signs of nutrient deficiency or metabolic issues.
• Lab work coordination — we can order and review blood panels locally, catching potential issues before they become problems.
• Integrated care — at Solas Health, GLP-1 therapy is part of a broader wellness approach. We can combine your weight loss program with IV therapy for hydration and nutrients, peptide therapy for metabolism support, and functional medicine to address root causes.
• Accountability — regular check-ins with a provider who knows you by name make a real difference in long-term success.